What is a tinib drug? A Deep Dive into Tyrosine Kinase Inhibitors
•
4 min read
The development of imatinib, the first approved tyrosine kinase inhibitor, revolutionized the treatment landscape for chronic myeloid leukemia (CML), transforming a fatal disease into a manageable chronic condition for many patients. This groundbreaking innovation introduced the world to the power of a **tinib drug**, a targeted medication ending in the suffix “-tinib.”
